Health
Nasal spray can reduce COVID-19 growth by up to 96%: Study – Yahoo Singapore News
New Delhi, Sep 28: Australian biotech company Ena Respiratory has said a nasal spray that it is developing to improve human immune system to fight common cold and flu significantly reduced coronavirus growth in a recent study on animals. INNA-051
New Delhi, Sep 28: Australian biotech company Ena Respiratory has said a nasal spray that it is developing to improve human immune system to fight common cold and flu significantly reduced coronavirus growth in a recent study on animals.
INNA-051 reduced COVID-19 viral replication by up to 96 per cent in ferrets, the company said.
The study was led by British government agency Public Health England.
The study on ferrets showed the product dubbed INNA-051, which could be used complementary to …
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM